National Research Corp. (NASDAQ:NRCIB) CEO Michael D. Hays sold 3,533 shares of the business’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $16.19, for a total value of $57,199.27. Following the sale, the chief executive officer now directly owns 6,467,744 shares in the company, valued at approximately $104,712,775.36. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

National Research Corp. (NASDAQ:NRCIB) opened at 34.69 on Friday. The company has a market cap of $840.23 million, a PE ratio of 42.62 and a beta of 0.28. The firm has a 50 day moving average price of $33.97 and a 200 day moving average price of $35.16. National Research Corp. has a 12-month low of $31.36 and a 12-month high of $44.60.

National Research Corp. (NASDAQ:NRCIB) last posted its quarterly earnings results on Tuesday, August 2nd. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.18. National Research Corp. had a net margin of 18.75% and a return on equity of 33.74%. On average, analysts anticipate that National Research Corp. will post $0.82 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 14th. Stockholders of record on Friday, September 30th will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 5.53%. The ex-dividend date of this dividend is Wednesday, September 28th. National Research Corp.’s payout ratio is 408.52%.

Separately, Zacks Investment Research raised National Research Corp. from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a report on Friday, August 12th.

An institutional investor recently bought a new position in National Research Corp. stock. Willis Investment Counsel acquired a new stake in National Research Corp. (NASDAQ:NRCIB) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 13,329 shares of the company’s stock, valued at approximately $442,000. Willis Investment Counsel owned 0.06% of National Research Corp. as of its most recent SEC filing. Institutional investors and hedge funds own 2.90% of the company’s stock.

National Research Corp. is a business services company in the Health Care Services industry.

5 Day Chart for NASDAQ:NRCIB

Receive News & Ratings for National Research Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corp. and related companies with's FREE daily email newsletter.